Upgrade to SI Premium - Free Trial

UBS Reiterates Neutral Rating on Clorox (CLX) Amid Lack of Visibility Into Earnings, Revenue

April 22, 2026 9:33 AM
UBS analyst Peter Grom reiterated a Neutral rating and $110.00 price target on Clorox (NYSE: CLX).The analyst commented, "CLX is ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments